Global Recombinant Protein Drug R & D Market Insights, Forecast to 2029
This report presents an overview of global market for Recombinant Protein Drug R & D market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Recombinant Protein Drug R & D, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Protein Drug R & D, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Protein Drug R & D revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Recombinant Protein Drug R & D market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Recombinant Protein Drug R & D revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci and Ankebio, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Protein Drug R & D in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Drug R & D companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Drug R & D revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Recombinant Protein Drug R & D, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Protein Drug R & D, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Protein Drug R & D revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Recombinant Protein Drug R & D market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Recombinant Protein Drug R & D revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci and Ankebio, etc.
By Company
- Eli Lilly
- Novo Nordisk
- Amgen
- Merck
- Sanofi
- Pfizer
- Roche
- Gensci
- Ankebio
- United Cell
- Sinobioway Hygene
- Kexing
- Dongbao
- 3sbio
- Gan&Lee
- Hengrui
- Peptide Hormones
- Hematopoietic Factor
- Cytokines
- Plasma Protein Factor
- Recombinase
- Fusion Protein
- Other
- Diabetes
- Dwarfism
- Hemophilia
- Heart Disease
- Cancer
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Protein Drug R & D in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Drug R & D companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Drug R & D revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Drug R & D Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Peptide Hormones
1.2.3 Hematopoietic Factor
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinase
1.2.7 Fusion Protein
1.2.8 Other
1.3 Market by Application
1.3.1 Global Recombinant Protein Drug R & D Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Hemophilia
1.3.5 Heart Disease
1.3.6 Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Recombinant Protein Drug R & D Market Perspective (2018-2029)
2.2 Global Recombinant Protein Drug R & D Growth Trends by Region
2.2.1 Recombinant Protein Drug R & D Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Recombinant Protein Drug R & D Historic Market Size by Region (2018-2023)
2.2.3 Recombinant Protein Drug R & D Forecasted Market Size by Region (2024-2029)
2.3 Recombinant Protein Drug R & D Market Dynamics
2.3.1 Recombinant Protein Drug R & D Industry Trends
2.3.2 Recombinant Protein Drug R & D Market Drivers
2.3.3 Recombinant Protein Drug R & D Market Challenges
2.3.4 Recombinant Protein Drug R & D Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Recombinant Protein Drug R & D by Players
3.1.1 Global Recombinant Protein Drug R & D Revenue by Players (2018-2023)
3.1.2 Global Recombinant Protein Drug R & D Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Protein Drug R & D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Recombinant Protein Drug R & D, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Recombinant Protein Drug R & D Market Concentration Ratio
3.4.1 Global Recombinant Protein Drug R & D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Drug R & D Revenue in 2022
3.5 Global Key Players of Recombinant Protein Drug R & D Head office and Area Served
3.6 Global Key Players of Recombinant Protein Drug R & D, Product and Application
3.7 Global Key Players of Recombinant Protein Drug R & D, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RECOMBINANT PROTEIN DRUG R & D BREAKDOWN DATA BY TYPE
4.1 Global Recombinant Protein Drug R & D Historic Market Size by Type (2018-2023)
4.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2024-2029)
5 RECOMBINANT PROTEIN DRUG R & D BREAKDOWN DATA BY APPLICATION
5.1 Global Recombinant Protein Drug R & D Historic Market Size by Application (2018-2023)
5.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Recombinant Protein Drug R & D Market Size (2018-2029)
6.2 North America Recombinant Protein Drug R & D Market Size by Type
6.2.1 North America Recombinant Protein Drug R & D Market Size by Type (2018-2023)
6.2.2 North America Recombinant Protein Drug R & D Market Size by Type (2024-2029)
6.2.3 North America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
6.3 North America Recombinant Protein Drug R & D Market Size by Application
6.3.1 North America Recombinant Protein Drug R & D Market Size by Application (2018-2023)
6.3.2 North America Recombinant Protein Drug R & D Market Size by Application (2024-2029)
6.3.3 North America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
6.4 North America Recombinant Protein Drug R & D Market Size by Country
6.4.1 North America Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Recombinant Protein Drug R & D Market Size by Country (2018-2023)
6.4.3 North America Recombinant Protein Drug R & D Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Recombinant Protein Drug R & D Market Size (2018-2029)
7.2 Europe Recombinant Protein Drug R & D Market Size by Type
7.2.1 Europe Recombinant Protein Drug R & D Market Size by Type (2018-2023)
7.2.2 Europe Recombinant Protein Drug R & D Market Size by Type (2024-2029)
7.2.3 Europe Recombinant Protein Drug R & D Market Share by Type (2018-2029)
7.3 Europe Recombinant Protein Drug R & D Market Size by Application
7.3.1 Europe Recombinant Protein Drug R & D Market Size by Application (2018-2023)
7.3.2 Europe Recombinant Protein Drug R & D Market Size by Application (2024-2029)
7.3.3 Europe Recombinant Protein Drug R & D Market Share by Application (2018-2029)
7.4 Europe Recombinant Protein Drug R & D Market Size by Country
7.4.1 Europe Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Recombinant Protein Drug R & D Market Size by Country (2018-2023)
7.4.3 Europe Recombinant Protein Drug R & D Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Recombinant Protein Drug R & D Market Size (2018-2029)
8.2 China Recombinant Protein Drug R & D Market Size by Type
8.2.1 China Recombinant Protein Drug R & D Market Size by Type (2018-2023)
8.2.2 China Recombinant Protein Drug R & D Market Size by Type (2024-2029)
8.2.3 China Recombinant Protein Drug R & D Market Share by Type (2018-2029)
8.3 China Recombinant Protein Drug R & D Market Size by Application
8.3.1 China Recombinant Protein Drug R & D Market Size by Application (2018-2023)
8.3.2 China Recombinant Protein Drug R & D Market Size by Application (2024-2029)
8.3.3 China Recombinant Protein Drug R & D Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Recombinant Protein Drug R & D Market Size (2018-2029)
9.2 Asia Recombinant Protein Drug R & D Market Size by Type
9.2.1 Asia Recombinant Protein Drug R & D Market Size by Type (2018-2023)
9.2.2 Asia Recombinant Protein Drug R & D Market Size by Type (2024-2029)
9.2.3 Asia Recombinant Protein Drug R & D Market Share by Type (2018-2029)
9.3 Asia Recombinant Protein Drug R & D Market Size by Application
9.3.1 Asia Recombinant Protein Drug R & D Market Size by Application (2018-2023)
9.3.2 Asia Recombinant Protein Drug R & D Market Size by Application (2024-2029)
9.3.3 Asia Recombinant Protein Drug R & D Market Share by Application (2018-2029)
9.4 Asia Recombinant Protein Drug R & D Market Size by Region
9.4.1 Asia Recombinant Protein Drug R & D Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Recombinant Protein Drug R & D Market Size by Region (2018-2023)
9.4.3 Asia Recombinant Protein Drug R & D Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type
10.2.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application
10.3.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country
10.4.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Recombinant Protein Drug R & D Introduction
11.1.4 Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.1.5 Eli Lilly Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Recombinant Protein Drug R & D Introduction
11.2.4 Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.2.5 Novo Nordisk Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Recombinant Protein Drug R & D Introduction
11.3.4 Amgen Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.3.5 Amgen Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Recombinant Protein Drug R & D Introduction
11.4.4 Merck Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.4.5 Merck Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Recombinant Protein Drug R & D Introduction
11.5.4 Sanofi Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.5.5 Sanofi Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Recombinant Protein Drug R & D Introduction
11.6.4 Pfizer Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.6.5 Pfizer Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Recombinant Protein Drug R & D Introduction
11.7.4 Roche Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.7.5 Roche Recent Developments
11.8 Gensci
11.8.1 Gensci Company Details
11.8.2 Gensci Business Overview
11.8.3 Gensci Recombinant Protein Drug R & D Introduction
11.8.4 Gensci Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.8.5 Gensci Recent Developments
11.9 Ankebio
11.9.1 Ankebio Company Details
11.9.2 Ankebio Business Overview
11.9.3 Ankebio Recombinant Protein Drug R & D Introduction
11.9.4 Ankebio Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.9.5 Ankebio Recent Developments
11.10 United Cell
11.10.1 United Cell Company Details
11.10.2 United Cell Business Overview
11.10.3 United Cell Recombinant Protein Drug R & D Introduction
11.10.4 United Cell Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.10.5 United Cell Recent Developments
11.11 Sinobioway Hygene
11.11.1 Sinobioway Hygene Company Details
11.11.2 Sinobioway Hygene Business Overview
11.11.3 Sinobioway Hygene Recombinant Protein Drug R & D Introduction
11.11.4 Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.11.5 Sinobioway Hygene Recent Developments
11.12 Kexing
11.12.1 Kexing Company Details
11.12.2 Kexing Business Overview
11.12.3 Kexing Recombinant Protein Drug R & D Introduction
11.12.4 Kexing Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.12.5 Kexing Recent Developments
11.13 Dongbao
11.13.1 Dongbao Company Details
11.13.2 Dongbao Business Overview
11.13.3 Dongbao Recombinant Protein Drug R & D Introduction
11.13.4 Dongbao Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.13.5 Dongbao Recent Developments
11.14 3sbio
11.14.1 3sbio Company Details
11.14.2 3sbio Business Overview
11.14.3 3sbio Recombinant Protein Drug R & D Introduction
11.14.4 3sbio Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.14.5 3sbio Recent Developments
11.15 Gan&Lee
11.15.1 Gan&Lee Company Details
11.15.2 Gan&Lee Business Overview
11.15.3 Gan&Lee Recombinant Protein Drug R & D Introduction
11.15.4 Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.15.5 Gan&Lee Recent Developments
11.16 Hengrui
11.16.1 Hengrui Company Details
11.16.2 Hengrui Business Overview
11.16.3 Hengrui Recombinant Protein Drug R & D Introduction
11.16.4 Hengrui Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.16.5 Hengrui Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Drug R & D Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Peptide Hormones
1.2.3 Hematopoietic Factor
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinase
1.2.7 Fusion Protein
1.2.8 Other
1.3 Market by Application
1.3.1 Global Recombinant Protein Drug R & D Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Hemophilia
1.3.5 Heart Disease
1.3.6 Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Recombinant Protein Drug R & D Market Perspective (2018-2029)
2.2 Global Recombinant Protein Drug R & D Growth Trends by Region
2.2.1 Recombinant Protein Drug R & D Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Recombinant Protein Drug R & D Historic Market Size by Region (2018-2023)
2.2.3 Recombinant Protein Drug R & D Forecasted Market Size by Region (2024-2029)
2.3 Recombinant Protein Drug R & D Market Dynamics
2.3.1 Recombinant Protein Drug R & D Industry Trends
2.3.2 Recombinant Protein Drug R & D Market Drivers
2.3.3 Recombinant Protein Drug R & D Market Challenges
2.3.4 Recombinant Protein Drug R & D Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Recombinant Protein Drug R & D by Players
3.1.1 Global Recombinant Protein Drug R & D Revenue by Players (2018-2023)
3.1.2 Global Recombinant Protein Drug R & D Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Protein Drug R & D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Recombinant Protein Drug R & D, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Recombinant Protein Drug R & D Market Concentration Ratio
3.4.1 Global Recombinant Protein Drug R & D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Drug R & D Revenue in 2022
3.5 Global Key Players of Recombinant Protein Drug R & D Head office and Area Served
3.6 Global Key Players of Recombinant Protein Drug R & D, Product and Application
3.7 Global Key Players of Recombinant Protein Drug R & D, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RECOMBINANT PROTEIN DRUG R & D BREAKDOWN DATA BY TYPE
4.1 Global Recombinant Protein Drug R & D Historic Market Size by Type (2018-2023)
4.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2024-2029)
5 RECOMBINANT PROTEIN DRUG R & D BREAKDOWN DATA BY APPLICATION
5.1 Global Recombinant Protein Drug R & D Historic Market Size by Application (2018-2023)
5.2 Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Recombinant Protein Drug R & D Market Size (2018-2029)
6.2 North America Recombinant Protein Drug R & D Market Size by Type
6.2.1 North America Recombinant Protein Drug R & D Market Size by Type (2018-2023)
6.2.2 North America Recombinant Protein Drug R & D Market Size by Type (2024-2029)
6.2.3 North America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
6.3 North America Recombinant Protein Drug R & D Market Size by Application
6.3.1 North America Recombinant Protein Drug R & D Market Size by Application (2018-2023)
6.3.2 North America Recombinant Protein Drug R & D Market Size by Application (2024-2029)
6.3.3 North America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
6.4 North America Recombinant Protein Drug R & D Market Size by Country
6.4.1 North America Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Recombinant Protein Drug R & D Market Size by Country (2018-2023)
6.4.3 North America Recombinant Protein Drug R & D Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Recombinant Protein Drug R & D Market Size (2018-2029)
7.2 Europe Recombinant Protein Drug R & D Market Size by Type
7.2.1 Europe Recombinant Protein Drug R & D Market Size by Type (2018-2023)
7.2.2 Europe Recombinant Protein Drug R & D Market Size by Type (2024-2029)
7.2.3 Europe Recombinant Protein Drug R & D Market Share by Type (2018-2029)
7.3 Europe Recombinant Protein Drug R & D Market Size by Application
7.3.1 Europe Recombinant Protein Drug R & D Market Size by Application (2018-2023)
7.3.2 Europe Recombinant Protein Drug R & D Market Size by Application (2024-2029)
7.3.3 Europe Recombinant Protein Drug R & D Market Share by Application (2018-2029)
7.4 Europe Recombinant Protein Drug R & D Market Size by Country
7.4.1 Europe Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Recombinant Protein Drug R & D Market Size by Country (2018-2023)
7.4.3 Europe Recombinant Protein Drug R & D Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Recombinant Protein Drug R & D Market Size (2018-2029)
8.2 China Recombinant Protein Drug R & D Market Size by Type
8.2.1 China Recombinant Protein Drug R & D Market Size by Type (2018-2023)
8.2.2 China Recombinant Protein Drug R & D Market Size by Type (2024-2029)
8.2.3 China Recombinant Protein Drug R & D Market Share by Type (2018-2029)
8.3 China Recombinant Protein Drug R & D Market Size by Application
8.3.1 China Recombinant Protein Drug R & D Market Size by Application (2018-2023)
8.3.2 China Recombinant Protein Drug R & D Market Size by Application (2024-2029)
8.3.3 China Recombinant Protein Drug R & D Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Recombinant Protein Drug R & D Market Size (2018-2029)
9.2 Asia Recombinant Protein Drug R & D Market Size by Type
9.2.1 Asia Recombinant Protein Drug R & D Market Size by Type (2018-2023)
9.2.2 Asia Recombinant Protein Drug R & D Market Size by Type (2024-2029)
9.2.3 Asia Recombinant Protein Drug R & D Market Share by Type (2018-2029)
9.3 Asia Recombinant Protein Drug R & D Market Size by Application
9.3.1 Asia Recombinant Protein Drug R & D Market Size by Application (2018-2023)
9.3.2 Asia Recombinant Protein Drug R & D Market Size by Application (2024-2029)
9.3.3 Asia Recombinant Protein Drug R & D Market Share by Application (2018-2029)
9.4 Asia Recombinant Protein Drug R & D Market Size by Region
9.4.1 Asia Recombinant Protein Drug R & D Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Recombinant Protein Drug R & D Market Size by Region (2018-2023)
9.4.3 Asia Recombinant Protein Drug R & D Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type
10.2.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application
10.3.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country
10.4.1 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Recombinant Protein Drug R & D Introduction
11.1.4 Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.1.5 Eli Lilly Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Recombinant Protein Drug R & D Introduction
11.2.4 Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.2.5 Novo Nordisk Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Recombinant Protein Drug R & D Introduction
11.3.4 Amgen Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.3.5 Amgen Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Recombinant Protein Drug R & D Introduction
11.4.4 Merck Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.4.5 Merck Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Recombinant Protein Drug R & D Introduction
11.5.4 Sanofi Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.5.5 Sanofi Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Recombinant Protein Drug R & D Introduction
11.6.4 Pfizer Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.6.5 Pfizer Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Recombinant Protein Drug R & D Introduction
11.7.4 Roche Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.7.5 Roche Recent Developments
11.8 Gensci
11.8.1 Gensci Company Details
11.8.2 Gensci Business Overview
11.8.3 Gensci Recombinant Protein Drug R & D Introduction
11.8.4 Gensci Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.8.5 Gensci Recent Developments
11.9 Ankebio
11.9.1 Ankebio Company Details
11.9.2 Ankebio Business Overview
11.9.3 Ankebio Recombinant Protein Drug R & D Introduction
11.9.4 Ankebio Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.9.5 Ankebio Recent Developments
11.10 United Cell
11.10.1 United Cell Company Details
11.10.2 United Cell Business Overview
11.10.3 United Cell Recombinant Protein Drug R & D Introduction
11.10.4 United Cell Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.10.5 United Cell Recent Developments
11.11 Sinobioway Hygene
11.11.1 Sinobioway Hygene Company Details
11.11.2 Sinobioway Hygene Business Overview
11.11.3 Sinobioway Hygene Recombinant Protein Drug R & D Introduction
11.11.4 Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.11.5 Sinobioway Hygene Recent Developments
11.12 Kexing
11.12.1 Kexing Company Details
11.12.2 Kexing Business Overview
11.12.3 Kexing Recombinant Protein Drug R & D Introduction
11.12.4 Kexing Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.12.5 Kexing Recent Developments
11.13 Dongbao
11.13.1 Dongbao Company Details
11.13.2 Dongbao Business Overview
11.13.3 Dongbao Recombinant Protein Drug R & D Introduction
11.13.4 Dongbao Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.13.5 Dongbao Recent Developments
11.14 3sbio
11.14.1 3sbio Company Details
11.14.2 3sbio Business Overview
11.14.3 3sbio Recombinant Protein Drug R & D Introduction
11.14.4 3sbio Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.14.5 3sbio Recent Developments
11.15 Gan&Lee
11.15.1 Gan&Lee Company Details
11.15.2 Gan&Lee Business Overview
11.15.3 Gan&Lee Recombinant Protein Drug R & D Introduction
11.15.4 Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.15.5 Gan&Lee Recent Developments
11.16 Hengrui
11.16.1 Hengrui Company Details
11.16.2 Hengrui Business Overview
11.16.3 Hengrui Recombinant Protein Drug R & D Introduction
11.16.4 Hengrui Revenue in Recombinant Protein Drug R & D Business (2018-2023)
11.16.5 Hengrui Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Recombinant Protein Drug R & D Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Peptide Hormones
Table 3. Key Players of Hematopoietic Factor
Table 4. Key Players of Cytokines
Table 5. Key Players of Plasma Protein Factor
Table 6. Key Players of Recombinase
Table 7. Key Players of Fusion Protein
Table 8. Key Players of Other
Table 9. Global Recombinant Protein Drug R & D Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Recombinant Protein Drug R & D Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Recombinant Protein Drug R & D Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Recombinant Protein Drug R & D Market Share by Region (2018-2023)
Table 13. Global Recombinant Protein Drug R & D Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Recombinant Protein Drug R & D Market Share by Region (2024-2029)
Table 15. Recombinant Protein Drug R & D Market Trends
Table 16. Recombinant Protein Drug R & D Market Drivers
Table 17. Recombinant Protein Drug R & D Market Challenges
Table 18. Recombinant Protein Drug R & D Market Restraints
Table 19. Global Recombinant Protein Drug R & D Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Recombinant Protein Drug R & D Revenue Share by Players (2018-2023)
Table 21. Global Top Recombinant Protein Drug R & D by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2022)
Table 22. Global Recombinant Protein Drug R & D Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Recombinant Protein Drug R & D Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Recombinant Protein Drug R & D, Headquarters and Area Served
Table 25. Global Key Players of Recombinant Protein Drug R & D, Product and Application
Table 26. Global Key Players of Recombinant Protein Drug R & D, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2018-2023)
Table 30. Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2024-2029)
Table 32. Global Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Recombinant Protein Drug R & D Revenue Share by Application (2018-2023)
Table 34. Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Recombinant Protein Drug R & D Revenue Share by Application (2024-2029)
Table 36. North America Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Recombinant Protein Drug R & D Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Recombinant Protein Drug R & D Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Recombinant Protein Drug R & D Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recombinant Protein Drug R & D Product
Table 71. Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 72. Eli Lilly Recent Developments
Table 73. Novo Nordisk Company Details
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Recombinant Protein Drug R & D Product
Table 76. Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 77. Novo Nordisk Recent Developments
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Recombinant Protein Drug R & D Product
Table 81. Amgen Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 82. Amgen Recent Developments
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Recombinant Protein Drug R & D Product
Table 86. Merck Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 87. Merck Recent Developments
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Recombinant Protein Drug R & D Product
Table 91. Sanofi Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Recombinant Protein Drug R & D Product
Table 96. Pfizer Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Recombinant Protein Drug R & D Product
Table 101. Roche Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 102. Roche Recent Developments
Table 103. Gensci Company Details
Table 104. Gensci Business Overview
Table 105. Gensci Recombinant Protein Drug R & D Product
Table 106. Gensci Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 107. Gensci Recent Developments
Table 108. Ankebio Company Details
Table 109. Ankebio Business Overview
Table 110. Ankebio Recombinant Protein Drug R & D Product
Table 111. Ankebio Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 112. Ankebio Recent Developments
Table 113. United Cell Company Details
Table 114. United Cell Business Overview
Table 115. United Cell Recombinant Protein Drug R & D Product
Table 116. United Cell Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 117. United Cell Recent Developments
Table 118. Sinobioway Hygene Company Details
Table 119. Sinobioway Hygene Business Overview
Table 120. Sinobioway Hygene Recombinant Protein Drug R & D Product
Table 121. Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 122. Sinobioway Hygene Recent Developments
Table 123. Kexing Company Details
Table 124. Kexing Business Overview
Table 125. Kexing Recombinant Protein Drug R & D Product
Table 126. Kexing Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 127. Kexing Recent Developments
Table 128. Dongbao Company Details
Table 129. Dongbao Business Overview
Table 130. Dongbao Recombinant Protein Drug R & D Product
Table 131. Dongbao Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 132. Dongbao Recent Developments
Table 133. 3sbio Company Details
Table 134. 3sbio Business Overview
Table 135. 3sbio Recombinant Protein Drug R & D Product
Table 136. 3sbio Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 137. 3sbio Recent Developments
Table 138. Gan&Lee Company Details
Table 139. Gan&Lee Business Overview
Table 140. Gan&Lee Recombinant Protein Drug R & D Product
Table 141. Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 142. Gan&Lee Recent Developments
Table 143. Hengrui Company Details
Table 144. Hengrui Business Overview
Table 145. Hengrui Recombinant Protein Drug R & D Product
Table 146. Hengrui Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 147. Hengrui Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 1. Global Recombinant Protein Drug R & D Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Peptide Hormones
Table 3. Key Players of Hematopoietic Factor
Table 4. Key Players of Cytokines
Table 5. Key Players of Plasma Protein Factor
Table 6. Key Players of Recombinase
Table 7. Key Players of Fusion Protein
Table 8. Key Players of Other
Table 9. Global Recombinant Protein Drug R & D Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Recombinant Protein Drug R & D Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Recombinant Protein Drug R & D Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Recombinant Protein Drug R & D Market Share by Region (2018-2023)
Table 13. Global Recombinant Protein Drug R & D Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Recombinant Protein Drug R & D Market Share by Region (2024-2029)
Table 15. Recombinant Protein Drug R & D Market Trends
Table 16. Recombinant Protein Drug R & D Market Drivers
Table 17. Recombinant Protein Drug R & D Market Challenges
Table 18. Recombinant Protein Drug R & D Market Restraints
Table 19. Global Recombinant Protein Drug R & D Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Recombinant Protein Drug R & D Revenue Share by Players (2018-2023)
Table 21. Global Top Recombinant Protein Drug R & D by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2022)
Table 22. Global Recombinant Protein Drug R & D Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Recombinant Protein Drug R & D Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Recombinant Protein Drug R & D, Headquarters and Area Served
Table 25. Global Key Players of Recombinant Protein Drug R & D, Product and Application
Table 26. Global Key Players of Recombinant Protein Drug R & D, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2018-2023)
Table 30. Global Recombinant Protein Drug R & D Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Recombinant Protein Drug R & D Revenue Market Share by Type (2024-2029)
Table 32. Global Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Recombinant Protein Drug R & D Revenue Share by Application (2018-2023)
Table 34. Global Recombinant Protein Drug R & D Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Recombinant Protein Drug R & D Revenue Share by Application (2024-2029)
Table 36. North America Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Recombinant Protein Drug R & D Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Recombinant Protein Drug R & D Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Recombinant Protein Drug R & D Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size by Country (2024-2029) & (US$ Million)
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Recombinant Protein Drug R & D Product
Table 71. Eli Lilly Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 72. Eli Lilly Recent Developments
Table 73. Novo Nordisk Company Details
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Recombinant Protein Drug R & D Product
Table 76. Novo Nordisk Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 77. Novo Nordisk Recent Developments
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Recombinant Protein Drug R & D Product
Table 81. Amgen Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 82. Amgen Recent Developments
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Recombinant Protein Drug R & D Product
Table 86. Merck Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 87. Merck Recent Developments
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Recombinant Protein Drug R & D Product
Table 91. Sanofi Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Recombinant Protein Drug R & D Product
Table 96. Pfizer Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Recombinant Protein Drug R & D Product
Table 101. Roche Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 102. Roche Recent Developments
Table 103. Gensci Company Details
Table 104. Gensci Business Overview
Table 105. Gensci Recombinant Protein Drug R & D Product
Table 106. Gensci Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 107. Gensci Recent Developments
Table 108. Ankebio Company Details
Table 109. Ankebio Business Overview
Table 110. Ankebio Recombinant Protein Drug R & D Product
Table 111. Ankebio Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 112. Ankebio Recent Developments
Table 113. United Cell Company Details
Table 114. United Cell Business Overview
Table 115. United Cell Recombinant Protein Drug R & D Product
Table 116. United Cell Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 117. United Cell Recent Developments
Table 118. Sinobioway Hygene Company Details
Table 119. Sinobioway Hygene Business Overview
Table 120. Sinobioway Hygene Recombinant Protein Drug R & D Product
Table 121. Sinobioway Hygene Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 122. Sinobioway Hygene Recent Developments
Table 123. Kexing Company Details
Table 124. Kexing Business Overview
Table 125. Kexing Recombinant Protein Drug R & D Product
Table 126. Kexing Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 127. Kexing Recent Developments
Table 128. Dongbao Company Details
Table 129. Dongbao Business Overview
Table 130. Dongbao Recombinant Protein Drug R & D Product
Table 131. Dongbao Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 132. Dongbao Recent Developments
Table 133. 3sbio Company Details
Table 134. 3sbio Business Overview
Table 135. 3sbio Recombinant Protein Drug R & D Product
Table 136. 3sbio Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 137. 3sbio Recent Developments
Table 138. Gan&Lee Company Details
Table 139. Gan&Lee Business Overview
Table 140. Gan&Lee Recombinant Protein Drug R & D Product
Table 141. Gan&Lee Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 142. Gan&Lee Recent Developments
Table 143. Hengrui Company Details
Table 144. Hengrui Business Overview
Table 145. Hengrui Recombinant Protein Drug R & D Product
Table 146. Hengrui Revenue in Recombinant Protein Drug R & D Business (2018-2023) & (US$ Million)
Table 147. Hengrui Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Recombinant Protein Drug R & D Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Recombinant Protein Drug R & D Market Share by Type: 2022 VS 2029
Figure 3. Peptide Hormones Features
Figure 4. Hematopoietic Factor Features
Figure 5. Cytokines Features
Figure 6. Plasma Protein Factor Features
Figure 7. Recombinase Features
Figure 8. Fusion Protein Features
Figure 9. Other Features
Figure 10. Global Recombinant Protein Drug R & D Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Recombinant Protein Drug R & D Market Share by Application: 2022 VS 2029
Figure 12. Diabetes Case Studies
Figure 13. Dwarfism Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Heart Disease Case Studies
Figure 16. Cancer Case Studies
Figure 17. Other Case Studies
Figure 18. Recombinant Protein Drug R & D Report Years Considered
Figure 19. Global Recombinant Protein Drug R & D Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Recombinant Protein Drug R & D Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Recombinant Protein Drug R & D Market Share by Region: 2022 VS 2029
Figure 22. Global Recombinant Protein Drug R & D Market Share by Players in 2022
Figure 23. Global Top Recombinant Protein Drug R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Recombinant Protein Drug R & D Revenue in 2022
Figure 25. North America Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 27. North America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 28. North America Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 29. United States Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Canada Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 32. Europe Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 33. Europe Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 34. Europe Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 35. Germany Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. France Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. U.K. Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Italy Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Russia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 42. China Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 43. China Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 44. Asia Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 45. Asia Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 46. Asia Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 47. Asia Recombinant Protein Drug R & D Market Share by Region (2018-2029)
Figure 48. Japan Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. South Korea Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. China Taiwan Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Southeast Asia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. India Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Australia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 55. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 56. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 57. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 58. Brazil Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Mexico Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Turkey Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Israel Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. GCC Countries Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 64. Eli Lilly Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 65. Novo Nordisk Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 66. Amgen Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 67. Merck Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 68. Sanofi Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 69. Pfizer Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 70. Roche Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 71. Gensci Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 72. Ankebio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 73. United Cell Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 74. Sinobioway Hygene Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 75. Kexing Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 76. Dongbao Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 77. 3sbio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 78. Gan&Lee Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 79. Hengrui Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Figure 1. Global Recombinant Protein Drug R & D Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Recombinant Protein Drug R & D Market Share by Type: 2022 VS 2029
Figure 3. Peptide Hormones Features
Figure 4. Hematopoietic Factor Features
Figure 5. Cytokines Features
Figure 6. Plasma Protein Factor Features
Figure 7. Recombinase Features
Figure 8. Fusion Protein Features
Figure 9. Other Features
Figure 10. Global Recombinant Protein Drug R & D Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Recombinant Protein Drug R & D Market Share by Application: 2022 VS 2029
Figure 12. Diabetes Case Studies
Figure 13. Dwarfism Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Heart Disease Case Studies
Figure 16. Cancer Case Studies
Figure 17. Other Case Studies
Figure 18. Recombinant Protein Drug R & D Report Years Considered
Figure 19. Global Recombinant Protein Drug R & D Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Recombinant Protein Drug R & D Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Recombinant Protein Drug R & D Market Share by Region: 2022 VS 2029
Figure 22. Global Recombinant Protein Drug R & D Market Share by Players in 2022
Figure 23. Global Top Recombinant Protein Drug R & D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Drug R & D as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Recombinant Protein Drug R & D Revenue in 2022
Figure 25. North America Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 27. North America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 28. North America Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 29. United States Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Canada Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 32. Europe Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 33. Europe Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 34. Europe Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 35. Germany Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. France Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. U.K. Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Italy Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Russia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 42. China Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 43. China Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 44. Asia Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 45. Asia Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 46. Asia Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 47. Asia Recombinant Protein Drug R & D Market Share by Region (2018-2029)
Figure 48. Japan Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. South Korea Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. China Taiwan Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Southeast Asia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. India Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Australia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Size YoY (2018-2029) & (US$ Million)
Figure 55. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Type (2018-2029)
Figure 56. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Application (2018-2029)
Figure 57. Middle East, Africa, and Latin America Recombinant Protein Drug R & D Market Share by Country (2018-2029)
Figure 58. Brazil Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Mexico Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Turkey Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Israel Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. GCC Countries Recombinant Protein Drug R & D Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 64. Eli Lilly Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 65. Novo Nordisk Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 66. Amgen Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 67. Merck Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 68. Sanofi Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 69. Pfizer Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 70. Roche Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 71. Gensci Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 72. Ankebio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 73. United Cell Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 74. Sinobioway Hygene Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 75. Kexing Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 76. Dongbao Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 77. 3sbio Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 78. Gan&Lee Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 79. Hengrui Revenue Growth Rate in Recombinant Protein Drug R & D Business (2018-2023)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
